1) Morton CC, Nance WE. Newborn hearing screening-A silent revolution. N Eng J Med 2006;354:2151-64.
2) Year 2019 position statement. Principles and Guidelines for Early Hearing Detection and Intervention Programs. J Early Hear Detect Interv 2019;4:1-4.
3) 日本産科婦人科学会, 日本産婦人科医会編. 産婦人科診療ガイドライン-産科編2020. https://www.jsog.or.jp/activity/pdf/gl_sanka_2020.pdf
4) 片岡祐子. 新生児聴覚スクリーニングの現状と今後の課題. 日耳鼻 2019;122:1552-4.
5) 日本耳鼻咽喉科学会 福祉医療・乳幼児委員会. 新生児聴覚スクリーニングマニュアル-産科・小児科・耳鼻咽喉科医師, 助産師・看護師の皆様へ. http://www.jibika.or.jp/members/publish/hearing_screening.pdf
6) 厚生労働省. 令和元年度「新生児聴覚検査の実施状況等について」の調査結果を公表します. https://www.mhlw.go.jp/stf/newpage_17311.html
7) 宇佐美真一. 難聴の個別化医療を目指して:Toward per-sonalized medicine of deafness. 日耳鼻 2021;124:135-47.
8) 野口佳裕ほか. 次世代シークエンサーを用いた遺伝子診断のピットフォール. Audiology Japan 2018;61:129-35.
9) Usami SI, Nishio SY. The genetic etiology of hearing loss in Japan revealed by the social health insurance-based genetic testing of 10K patients. Hum Genet 2022;141:665-81.
10) 野口佳裕. 遺伝性難聴入門. Audiology Japan 2012;65:169-76.
11) 野口佳裕. 内耳奇形. Equilibrium Res 2015;74:247-56.
12) Hereditary Hearing Loss Homepage. https://hereditaryhearingloss.org
13) Jun AI, et al. Temporal bone histopathology in connexin 26-related hearing loss. Laryngoscope 2000;110:269-75.
14) Yasukawa R, et al. The prevalence and clinical characteris-tics of TECTA-associated autosomal dominant hearing loss. Genes(Basel)2019;10:744.
15) Marlin S, et al. Temperature-sensitive auditory neuropathy associated with an otoferlin mutation:Defending fever! Biochem Biophys Res Commun 2010;394:737-42.
16) Astuto LM, et al. CDH23 mutation and phenotype heteroge-neity:A profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. Am J Hum Genet 2002;71:262-75.
17) Yokota Y, et al. Frequency and clinical features of hearing loss caused by STRC deletions. Sci Rep 2019;9:4408.
18) Maekawa K, et al. Mutational spectrum and clinical features of patients with LOXHD1 variants identified in an 8074 hearing loss patient cohort. Genes(Basel)2019;10:735.